Drug Shortage Report for TEVA-TERBINAFINE

Last updated on 2020-02-13 History
Report ID 1655
Drug Identification Number 02240346
Brand name TEVA-TERBINAFINE
Common or Proper name TERBINAFINE
Company Name TEVA CANADA LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) TERBINAFINE
Strength(s) 250MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 28
ATC code D01BA
ATC description ANTIFUNGALS FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-10-18
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2020-02-13
Company comments Product is being evaluated
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2020-02-13 French Compare
v6 2020-02-13 English Compare
v5 2017-10-10 French Compare
v4 2017-10-10 English Compare
v3 2017-03-14 French Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare